ANDA 213705, held by Accord Hlthcare. Succinylcholine Chloride.
As of Nov 16, 2026, ANDA 213705 (Succinylcholine Chloride), held by Accord Hlthcare, was first approved by FDA on May 20, 2020, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 20, 2020 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Succinylcholine Chloride20MG/ML · injectable;injection | Succinylcholine Chloride | Discontinued |
| Oct 25, 2021 | Supplement 4Labeling · Standard review | Approved | None posted |
| May 20, 2020 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters